A Diversity of Clients. A Wealth of Expertise.
From global, multibillion-dollar corporations to small, privately held companies, Sapphire Sciences partners with a wide range of clients. Our team brings decades of experience in navigating regulatory landscapes and developing scientific strategies tailored to the unique needs of each organization.
Sapphire Sciences boasts a world-class team of senior-level scientists, clinicians, and engineers and a network of over 300 consultants. Our areas of expertise include:
With this diverse network, we can assemble custom project teams of any size to meet your needs.
We provide comprehensive scientific and regulatory solutions to clients engaging with regulatory authorities, including the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and Health Canada. Our services are designed to deliver trusted, data-driven insights that support compliance, innovation, and public health, including preparation of PMTAs, SEs, MRTPAs and TPMFs.
Our clients develop nicotine, tobacco, and cannabis products that focus on harm reduction, ranging from multinational corporations to small, entrepreneurial ventures. Whether you need strategic support for a complex regulatory submission or targeted scientific expertise, Sapphire Sciences is your trusted partner.
Sapphire Sciences is committed to being the leading provider of scientific and regulatory solutions for organizations that develop nicotine, tobacco, and cannabis products that focus on harm reduction. Our mission is rooted in the principle of being Appropriate for the Protection of Public Health (APPH) while delivering innovative solutions to our clients.
We are proud to serve organizations dedicated to creating products with the potential for harm reduction that improve public health outcomes.
